Paper33036656
High-throughput approaches for precision medicine in high-grade serous ovarian cancer.
Govindarajan M and 4 others. J Hematol Oncol, 2020. Cited by 63 papers, by iCite.
Cite this record
ConductScience Library. High-throughput approaches for precision medicine in high-grade serous ovarian cancer. Papers, record 33036656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33036656
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cystadenocarcinoma, Serous | Major topic |
| Ovarian Neoplasms | Major topic |
| Animals | |
| Antineoplastic Agents | |
| Biomarkers, Tumor | |
| Disease Management | |
| Drug Discovery | |
| Female | |
| Gene Expression Profiling | |
| Humans | |
| Liquid Biopsy | |
| Molecular Targeted Therapy | |
| Precision Medicine |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CIHR | Canada | PubMed |
Source PubMed
References197
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22006311 | Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/22006311 | PubMed |
| 2 | 15313933 | Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. | Cancer Res | 2004 | https://conductscience.org/library/papers/15313933 | PubMed |
| 3 | 15111296 | Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. | Am J Pathol | 2004 | https://conductscience.org/library/papers/15111296 | PubMed |
| 4 | 29359686 | Targeting RAS-driven human cancer cells with antibodies to upregulated and essential cell-surface proteins. | Elife | 2018 | https://conductscience.org/library/papers/29359686 | PubMed |
| 5 | 22331912 | High-grade serous ovarian cancer arises from fallopian tube in a mouse model. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22331912 | PubMed |
| 6 | 26002111 | Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial. | Lancet | 2015 | https://conductscience.org/library/papers/26002111 | PubMed |
| 7 | 22711857 | BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. | J Clin Oncol | 2012 | https://conductscience.org/library/papers/22711857 | PubMed |
| 8 | 22875782 | Does HE4 have a role as biomarker in the recurrence of ovarian cancer? | Tumour Biol | 2012 | https://conductscience.org/library/papers/22875782 | PubMed |
| 9 | 18827127 | Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors. | Obstet Gynecol | 2008 | https://conductscience.org/library/papers/18827127 | PubMed |
| 10 | 12488461 | The human plasma proteome: history, character, and diagnostic prospects. | Mol Cell Proteomics | 2002 | https://conductscience.org/library/papers/12488461 | PubMed |
| 11 | 22912394 | The promise of patient-derived xenografts: the best laid plans of mice and men. | Clin Cancer Res | 2012 | https://conductscience.org/library/papers/22912394 | PubMed |
| 12 | 21555961 | Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay. | Obstet Gynecol | 2011 | https://conductscience.org/library/papers/21555961 | PubMed |
| 13 | 11600607 | Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels. | J Clin Oncol | 2001 | https://conductscience.org/library/papers/11600607 | PubMed |
| 14 | 25304260 | Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations. | Cancer Res | 2014 | https://conductscience.org/library/papers/25304260 | PubMed |
| 15 | 24637997 | Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial. | J Clin Oncol | 2014 | https://conductscience.org/library/papers/24637997 | PubMed |
| 16 | 30092594 | Analysis of Circulating Tumor Cells in Ovarian Cancer and Their Clinical Value as a Biomarker. | Cell Physiol Biochem | 2018 | https://conductscience.org/library/papers/30092594 | PubMed |
| 17 | 28916367 | Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial. | Lancet | 2017 | https://conductscience.org/library/papers/28916367 | PubMed |
| 18 | 30981729 | N-Glycoproteomics of Patient-Derived Xenografts: A Strategy to Discover Tumor-Associated Proteins in High-Grade Serous Ovarian Cancer. | Cell Syst | 2019 | https://conductscience.org/library/papers/30981729 | PubMed |
| 19 | 21746896 | Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21746896 | PubMed |
| 20 | 17406594 | Solid-phase extraction of N-linked glycopeptides. | Nat Protoc | 2007 | https://conductscience.org/library/papers/17406594 | PubMed |
Cited by52
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42908017 | Early and accurate detection of ovarian cancer by profiling cell-free mitochondrial DNA fragmentomics in multi-ethnic population. | Genome Med | 2026 | https://conductscience.org/library/papers/42908017 | PubMed |
| 42568819 | Biomarkers for predicting and monitoring the efficacy of cancer vaccines. | Front Oncol | 2026 | https://conductscience.org/library/papers/42568819 | PubMed |
| 42479110 | Natural products targeting cytokine-regulated SASP inflammation networks in Ovarian cancer: Implications on immune escape and molecular resistance. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/42479110 | PubMed |
| 42069755 | Hypermethylation of ZNF154 promotes malignant potential of ovarian cancer cells by diminishing ZNF154/KAP1-mediated ROMO1 repression. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/42069755 | PubMed |
| 41634058 | Mechanisms of FOXK1-regulated glycolipid metabolism in mediating TOX-induced histone lactylation to promote CD8⁺ T cell exhaustion in high-grade serous ovarian cancer. | Sci Rep | 2026 | https://conductscience.org/library/papers/41634058 | PubMed |
| 41460259 | Distinct origins of high-grade serous ovarian carcinoma: genetic and epigenetic evidence linking ovarian and fallopian tube epithelium to clinical outcomes and early detection. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/41460259 | PubMed |
| 41361348 | Transcriptome analysis of orbital tissue in thyroid eye disease uncovers key pathogenic mediators. | Sci Rep | 2025 | https://conductscience.org/library/papers/41361348 | PubMed |
| 41044210 | ID8 cells manifest phenotypic plasticity and molecular heterogeneity of high-grade serous ovarian cancer in response to the local tissue niche. | Sci Rep | 2025 | https://conductscience.org/library/papers/41044210 | PubMed |
| 40696842 | A stage IV high-grade serous ovarian cancer patient carrying ERBB2 amplification and ERBB2 overexpression benefits from late-line pyrotinib treatment: A case report. | Sci Prog | 2025 | https://conductscience.org/library/papers/40696842 | PubMed |
| 40596104 | Cross modality learning of cell painting and transcriptomics data improves mechanism of action clustering and bioactivity modelling. | Sci Rep | 2025 | https://conductscience.org/library/papers/40596104 | PubMed |
| 40503412 | Functional heterogeneity and clinical implications of CD4+ T cell subtypes in high-grade serous ovarian carcinoma. | World J Clin Oncol | 2025 | https://conductscience.org/library/papers/40503412 | PubMed |
| 40416874 | Uncovering key regulatory pathways and prognostic biomarkers in the tumor microenvironment of high-grade serous ovarian cancer through single-cell RNA sequencing and experimental validation. | Front Oncol | 2025 | https://conductscience.org/library/papers/40416874 | PubMed |
| 40356909 | Epigenetic regulation in oogenesis and fetal development: insights into m6A modifications. | Front Immunol | 2025 | https://conductscience.org/library/papers/40356909 | PubMed |
| 40072054 | Establishment and Its Utility of a Patient-Derived Cell Xenografts (PDCX) Model with Cryopreserved Cancer Cells from Human Tumor. | Cells | 2025 | https://conductscience.org/library/papers/40072054 | PubMed |
| 39904996 | Epigenetic regulation in female reproduction: the impact of m6A on maternal-fetal health. | Cell Death Discov | 2025 | https://conductscience.org/library/papers/39904996 | PubMed |
| 39791510 | Early prediction and risk stratification of ovarian cancer based on clinical data using machine learning approaches. | J Gynecol Oncol | 2025 | https://conductscience.org/library/papers/39791510 | PubMed |
| 39669976 | Inhibition of Selenoprotein I promotes ferroptosis and reverses resistance to platinum chemotherapy by impairing Akt phosphorylation in ovarian cancer. | MedComm (2020) | 2024 | https://conductscience.org/library/papers/39669976 | PubMed |
| 39605897 | Transcriptomic era of cancers in females: new epigenetic perspectives and therapeutic prospects. | Front Oncol | 2024 | https://conductscience.org/library/papers/39605897 | PubMed |
| 39546194 | The Evolution of Next-Generation Sequencing Technologies. | Methods Mol Biol | 2025 | https://conductscience.org/library/papers/39546194 | PubMed |
| 39272653 | The Impact of Liquid Biopsy in Advanced Ovarian Cancer Care. | Diagnostics (Basel) | 2024 | https://conductscience.org/library/papers/39272653 | PubMed |
Genes28
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33036656
GET https://conductscience.org/api/papers/v1/33036656/references?page=2